← Back to Clinical Trials
Recruiting NCT06282887

NCT06282887 Effects of Music Therapy on Psychological States Among Cancer Patients Undergoing MRI Scans and a Relevant Mediator

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06282887
Status Recruiting
Phase
Sponsor Guangzhou Concord Cancer Center
Condition Psycho-Oncology
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2021-11-09
Primary Completion 2025-11-10

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Music therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2021-11-09 with a primary completion date of 2025-11-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The primary objective of this study is to examine the effects of a music therapy protocol on improving anxiety, symptom distress, and relaxation among cancer patients who are going through MRI scanning. Physiological data, such as pulse rates and respiration rates will be collected. Furthermore, data about scanning efficiency will be collected to assess if scanning efficiency is affected by the protocol implementation. The secondary study objective is to assess whether or not there is a relationship between patient attention to music during the intervention process and the changes in anxiety, symptom distress, and relaxation.

Eligibility Criteria

Inclusion Criteria: 1. The subject is diagnosed with cancer; 2. The subject is between 18- 60 years old; 3. The subject understands Mandarin, Cantonese, or English; 4. The subject did not use medication for sedatives, anxiolytics, and/or sleep aids; 5. The subject is awake without cognitive disorders; 6. the subject rates more than 0 on the 0-10 VAS for anxiety; 7. The subject has finished primary school level education. Exclusion Criteria: 1. The subject withdraws the MRI scan; 2. The subject needs other intervention(s) to complete the scan; 3. The subject has hearing and/or visual impairments; 4. The subject has a history of a severe somatic psychiatric disease or clinically diagnosed mental disorders.

Contact & Investigator

Central Contact

Yinglan He

✉ wing_____5@hotmail.com

📞 18320739030

Frequently Asked Questions

Who can join the NCT06282887 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Psycho-Oncology. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06282887 currently recruiting?

Yes, NCT06282887 is actively recruiting participants. Contact the research team at wing_____5@hotmail.com for enrollment information.

Where is the NCT06282887 trial being conducted?

This trial is being conducted at Guangzhou, China.

Who is sponsoring the NCT06282887 clinical trial?

NCT06282887 is sponsored by Guangzhou Concord Cancer Center. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology